Skip to content
Find a Provider
Nabeel Badri, M.B.Ch.B.

Nabeel Badri, M.B.Ch.B.

Hematology & Oncology , Cancer

4.9 out of 5 stars
203 Ratings
19 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Office (585) 275-5823
Fax (585) 275-1051

About Me

I am a medical oncologist at the Wilmot Cancer Institute, University of Rochester Medical Center. I am specialized in treating gastroenterology malignancies. My primary research interest has focused on gastrointestinal malignancies. Currently, I have been involved in various studies/clinical-trials ...
I am a medical oncologist at the Wilmot Cancer Institute, University of Rochester Medical Center. I am specialized in treating gastroenterology malignancies. My primary research interest has focused on gastrointestinal malignancies. Currently, I have been involved in various studies/clinical-trials investigating novel approaches and chemo-therapeutics to treat gastrointestinal cancer.

Conditions I treat:

* Esophageal cancer
* Stomach cancer
* Pancreatic cancer
* Colon cancer
* Rectal cancer
* Anal cancer
* Neuroendocrine tumors and carcinoid tumors
* Liver cancer: Hepatocellular carcinoma (HCC)
* Bile duct cancer
* Cholangiocarcinoma
* Appendiceal cancer and tumors

Faculty Appointments

Assistant Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematology & Oncology, University of Rochester Medical Center. 2018 - 2020

Fellowship, Hematology & Oncology, Howard University Hospital. 2017 - 2018

Residency, Internal Medicine, Texas Tech University Health Sciences Center-EP. 2015 - 2017

Internship, Internal Medicine, Texas Tech University Health Sciences Center-EP. 2014 - 2015

Education

MBBCH | Al-Kindy College of Medicine (Iraq). 2007

Awards

Fellow in Clinical Research Methodology Training Program, University of Rochester. 2022

Biochemistry Honor Roll. 2003

Pathophysiology Honor Roll. 2003

Research

Clinical Trials

The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing The Efficacy of Triplet Versus Doublet Chemotherapy to Achieve Clinical Complete Response in Patients With Locally Advanced Rectal Cancer

Lead Researcher: Nabeel Badri

This phase II trial compares the effect of irinotecan versus oxaliplatin after long-course chemoradiation in patients with stage II-III rectal cancer. Combination chemotherapy drugs, such as FOLFIRINOX (fluorouracil, irinotecan, leucovorin, and oxali...

Publications

Journal Articles

A Reassessment of the Clinical Utility of Ga-DOTATATE PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors.

Prela O, Caveney B, Strawderman M, Linehan D, Galka E, Schoeniger L, Hezel A, Badri N, Carpizo DR

Journal of surgical oncology.. 2025 January 5 Epub 01/05/2025.

Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma.

Badri N, Ngamdu KS, Torabi A, Guar S

Journal of cancer research and therapeutics.. 2020 16 (1):183-185. Epub 1900 01 01.

Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.

Nahleh Z, Otoukesh S, Mirshahidi HR, Nguyen AL, Nagaraj G, Botrus G, Badri N, Diab N, Alvarado A, Sanchez LA, Dwivedi AK

Cancer medicine. 2018 June 7 (6):2710-2717. Epub 05/07/2018.

Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy.

Elzamly S, Badri N, Padilla O, Dwivedi AK, Alvarado LA, Hamilton M, Diab N, Rock C, Elfar A, Teleb M, Sanchez L, Nahleh Z

Breast cancer : basic and clinical research.. 2018 12 :1178223418788074. Epub 08/01/2018.

Use of non-selective ?-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.

Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z

Oncotarget.. 2017 January 248 (4):6446-6460. Epub 1900 01 01.

Prevalence of Low Vitamin D in Patients with Breast Cancer in a Predominantly Hispanic Population at the American-Mexican Border.

Farrag SE, Dwivedi AK, Otoukesh S, Badri NJ, Sanchez LA, Nahleh ZA

Nutrition and cancer.. 2017 69 (6):819-824. Epub 07/18/2017.

Diffuse large B-cell non-Hodgkin's lymphoma and osteosclerotic myeloma with features of POEMS syndrome.

Ngamdu KS, Torabi A, Badri N, Teleb M, Gaur S

Proceedings. 2016 July 29 (3):306-8. Epub 1900 01 01.

Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.

Badri N, Teleb M, Syed S, Wardi M, Porres-Aguilar M, Cruz-Flores S

Case reports in neurology.. 2016 8 (2):102-7. Epub 05/24/2016.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.9 stars

Likelihood of recommending this care provider to others

4.9 stars

Explanations the care provider gave you about your problem or condition

4.9 stars

Care provider's efforts to include you in decisions about your care

4.9 stars

Concern the care provider showed for your questions or worries

4.9 stars

Patient Comments

5.0 stars

I'm very pleased with Dr. Badri.he has a very strong sense of my concerns and he is doing very well in keeping me informed about my condition and he shows care and compassion for me.he is very patient with me not being very knowledgeable.

Jan 19, 2025

5.0 stars

I'm very comfortable with Dr. Badri. I've spoke to my friends on how knowledgeable he is with my issue..

Jan 12, 2025

5.0 stars

Dr. Badri was very good in all of the above categories.

Jan 11, 2025

5.0 stars

Dr. Badri was wonderful,cares and takes the time with you and explains everything.

Dec 29, 2024

3.0 stars

To be honest this doctor is a little hard to communicate with.

Oct 27, 2024

5.0 stars

All good

Apr 19, 2024

5.0 stars

If there's a problem, my doctor's have been upfront and honest with me, which is exactly what I want.

Apr 03, 2024

5.0 stars

Always felt so very fortunate to get the wonderful care that I was getting ~

Mar 20, 2024

3.8 stars

This was an initial visit for a new, complex problem. I think we did the best we could to communicate with limited information. I am in no way suggesting that the provider lacked any skill. He was earnest and compassionate. It will take time for a clearer picture of the situation to emerge.

Dec 09, 2023

5.0 stars

Amazing how well run everything Is and very grateful for U of R andEspecially Dr. Badri and Megan Porter

Oct 28, 2023